NCT05853458 2026-04-07
HU-F-AIM
Novartis
Phase 4 Terminated
Clinical Trials
66 trialsNCT01673984 2025-05-23
GREAT
Ipsen
Phase 4 Terminated
NCT04506086 2025-05-18
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
Phase 4 Terminated
NCT03672643 2024-11-08
Long Term Safety Observation of Crizotinib in Chinese NSCLC Population
Pfizer
Phase 4 Terminated
NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
NCT01856023 2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4 Terminated
NCT01468623 2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4 Terminated
NCT04381494 2023-06-22
ON TRAX
AstraZeneca
Phase 4 Terminated
NCT03859869 2023-06-05
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
AbbVie
Phase 4 Terminated
NCT03971110 2022-12-16
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
AstraZeneca
Phase 4 Terminated
NCT01100879 2022-05-09
AOC-MM
Vifor Pharma
Phase 4 Terminated
NCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT02228382 2021-12-30
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Pfizer
Phase 4 Terminated
NCT04031885 2021-08-24
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Phase 4 Terminated
NCT02476994 2021-07-21
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion
Baxter Healthcare Corporation
Phase 4 Terminated
NCT01131325 2021-05-20
MACS1148
Novartis
Phase 4 Terminated
NCT00380874 2021-02-11
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Pfizer
Phase 4 Terminated
NCT01683188 2021-02-01
PROCLIVITY01
Clinigen, Inc.
Phase 4 Terminated
NCT00381095 2021-01-20
COPE
Pfizer
Phase 4 Terminated
NCT01760616 2020-03-06
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Qidong Gaitianli Medicines Co., Ltd
Phase 4 Terminated
NCT03460678 2020-03-05
Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.
Hikma Pharmaceuticals LLC
Phase 4 Terminated
NCT02739360 2020-03-04
Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
Gilead Sciences
Phase 4 Terminated
NCT00730847 2019-11-05
A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.
GlaxoSmithKline
Phase 4 Terminated
NCT00140894 2019-09-20
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT01806740 2019-08-08
DCE-MRI
Guerbet
Phase 4 Terminated
NCT03210324 2019-08-07
A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy
China Resources Zizhu Pharmaceutical Co., Ltd.
Phase 4 Terminated
NCT02895529 2019-05-06
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
Xian-Janssen Pharmaceutical Ltd.
Phase 4 Terminated
NCT03355079 2019-05-01
Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy
Fresenius Kabi
Phase 4 Terminated
NCT01283386 2019-03-14
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status
Hoffmann-La Roche
Phase 4 Terminated
NCT02204722 2018-06-15
IDEAL
Dong-A ST Co., Ltd.
Phase 4 Terminated
NCT02441517 2018-04-19
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Astellas Pharma Inc
Phase 4 Terminated
NCT01271010 2018-03-20
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
Hoffmann-La Roche
Phase 4 Terminated
NCT02287025 2017-10-19
SMART
Bayer
Phase 4 Terminated
NCT02695290 2017-09-18
Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
Boehringer Ingelheim
Phase 4 Terminated
NCT00375752 2017-06-26
FEMZONE
Novartis
Phase 4 Terminated
NCT00604968 2017-06-07
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT01315886 2017-04-05
Conversion From Fast Acting Oral Opioids to Abstral®
Orexo AB
Phase 4 Terminated
NCT01933022 2017-03-09
EFFECT
Astellas Pharma Inc
Phase 4 Terminated
NCT00087620 2017-02-03
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT00495378 2016-12-20
RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia
Ortho Biotech Products, L.P.
Phase 4 Terminated
NCT01260194 2016-11-02
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT02608060 2016-11-02
A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
Hoffmann-La Roche
Phase 4 Terminated
NCT02624141 2016-11-02
A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy
Hoffmann-La Roche
Phase 4 Terminated
NCT00944372 2016-09-09
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
Mallinckrodt
Phase 4 Terminated
NCT00642733 2016-08-24
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT02749825 2016-04-25
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Pharmatech
Phase 4 Terminated
NCT01756729 2016-03-02
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
NovoCure Ltd.
Phase 4 Terminated
NCT00747916 2015-07-16
Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")
CSA Medical, Inc.
Phase 4 Terminated
NCT00779285 2015-07-14
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT01706822 2015-03-18
Radial Reload Laparoscopic LAR Case Series
Medtronic - MITG
Phase 4 Terminated